Sodium Risedronate

PreclinicalSmall molecule

Takeda

Sodium Risedronate is one of 35 small molecule programs targeting Bone Fracture. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Bone FractureActive, not recruiting

Bone FracturePreclinical

Active, not recruiting

Competition

Competitive Landscape

41 competitors in Bone Fracture

#DrugCompanyPhaseTrials

Fareston

Kyowa Kirin Co., Ltd.

Epidiolex

Voltaren

Bayer Aspirin

Zometa

Keterol

PPamukkale University

Approved

1 7

Advil

KKenvue Brands

Approved

1 8

Toradol

JJavelin Pharmaceuticals

Approved

1 9

Tylenol

KKenvue Brands

Approved

1 10

Ultram

WWim Janssens

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Drug1 trial

Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -

Completed· Takeda logo

Takeda··NCT02106455·315 enrolled

Bone Fracture1 trial

36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets

Completed· Takeda logo

Takeda··NCT02106442·579 enrolled

Treatment1 trial

Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)

Completed· Takeda logo

Takeda··NCT02089997·3,304 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Sodium Risedronate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Sodium Risedronate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Sodium Risedronate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Takeda company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Takeda

Sodium Risedronate

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Drug1 trial

Bone Fracture1 trial

Treatment1 trial

References

Drug Info

Quick Facts

Related News